+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Arterial Thrombosis Drug"

Arterial Thrombosis - Pipeline Insight, 2024 - Product Thumbnail Image

Arterial Thrombosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Arterial Thrombosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Arterial Thrombosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 40 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

The Arterial Thrombosis Drug market is a subset of the Cardiovascular Drugs market, which focuses on the treatment of arterial thrombosis. Arterial thrombosis is a condition in which a blood clot forms in an artery, blocking the flow of blood to the heart, brain, or other organs. Arterial thrombosis drugs are used to reduce the risk of stroke, heart attack, and other cardiovascular events. These drugs work by preventing the formation of blood clots, or by dissolving existing clots. Commonly used drugs include anticoagulants, antiplatelet agents, and thrombolytics. Some companies in the Arterial Thrombosis Drug market include Bayer, Pfizer, Sanofi, Bristol-Myers Squibb, and Merck. Show Less Read more